Home LiteratureArticle Details
PMID: 2072454 Published · ppublish English Journal Article

Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types.

Journal of virology ·Vol. 65 ·No. 8 ·1991-08-00 ·Pages 4350-8

Ross EK, Buckler-White AJ, Rabson AB, Englund G, Martin MA

Abstract

Starting with a replication-incompetent molecular clone of human immunodeficiency virus type 1, lacking all the NF-kappa B and Sp1 binding sites present in the native long terminal repeat (LTR), proviruses containing reconstructed LTRs with individual or combinations of NF-kappa B and Sp1 elements were generated and evaluated for their capacity to produce virus progeny following transfection-cocultivation. Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element(s) was present in the LTR. For example, in experiments involving proviral clones with LTRs containing one or two NF-kappa B elements (and no Sp1 binding sites), a hierarchy of cellular permissivity to virus replication (peripheral blood lymphocytes = MT4 greater than H9 greater than CEM greater than Jurkat) was observed. Of note was the associated emergence of second-site LTR revertants which involved an alteration of the TATA box. These results suggest that the human immunodeficiency virus type 1 LTR possesses functional redundancy which ensures virus replication in different T-cell types and is capable of changing depending on the particular combination of transcriptional factors present.

MeSH Terms
Base Sequence Cell Line DNA Replication DNA, Viral/biosynthesis,chemistry Enhancer Elements, Genetic HIV-1/genetics,growth & development,physiology Humans Molecular Sequence Data Mutagenesis, Site-Directed NF-kappa B/genetics,metabolism Polymerase Chain Reaction Proviruses/genetics RNA, Viral/chemistry Repetitive Sequences, Nucleic Acid Sp1 Transcription Factor/genetics,metabolism T-Lymphocytes/microbiology Transfection Virus Replication
Chemicals
DNA, Viral NF-kappa B RNA, Viral Sp1 Transcription Factor
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Ross E K
Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
Buckler-White A J
Rabson A B
Englund G
Martin M A
References (43)
43 references, click to expand
  1. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.
    Proc Natl Acad Sci U S A. 1988 Jul;85(13):4700-4 PMID: 3133660
  2. Applications of the polymerase chain reaction in retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells.
    Hum Gene Ther. 1990 Summer;1(2):135-49 PMID: 1964093
  3. A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator.
    Mol Cell Biol. 1988 Jun;8(6):2555-61 PMID: 2841583
  4. Cooperativity and hierarchical levels of functional organization in the SV40 enhancer.
    Cell. 1988 Sep 23;54(7):943-53 PMID: 2843294
  5. Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR.
    Science. 1988 Sep 16;241(4872):1481-5 PMID: 3262235
  6. Activation of the U2 snRNA promoter by the octamer motif defines a new class of RNA polymerase II enhancer elements.
    Genes Dev. 1988 Dec;2(12B):1764-78 PMID: 2853685
  7. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation.
    EMBO J. 1989 Mar;8(3):765-78 PMID: 2721501
  8. Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat.
    Genes Dev. 1989 Apr;3(4):547-58 PMID: 2470647
  9. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat.
    J Virol. 1989 Jun;63(6):2585-91 PMID: 2657100
  10. Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication.
    J Virol. 1989 Sep;63(9):4115-9 PMID: 2760991
  11. The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity.
    J Virol. 1989 Nov;63(11):4919-24 PMID: 2795721
  12. Tat trans-activates the human immunodeficiency virus through a nascent RNA target.
    Cell. 1989 Oct 20;59(2):273-82 PMID: 2478293
  13. kappa B elements strongly activate gene expression in non-lymphoid cells and function synergistically with NF1 elements.
    Nucleic Acids Res. 1989 Oct 25;17(20):8197-206 PMID: 2510129
  14. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  15. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter.
    Cell. 1983 Nov;35(1):79-87 PMID: 6313230
  16. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.
    Science. 1984 May 4;224(4648):497-500 PMID: 6200935
  17. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level.
    J Immunol. 1984 Jul;133(1):123-8 PMID: 6327821
  18. Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template.
    DNA. 1984 Dec;3(6):479-88 PMID: 6096101
  19. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.
    Science. 1985 Jan 11;227(4683):171-3 PMID: 2981427
  20. Rapid and efficient site-specific mutagenesis without phenotypic selection.
    Proc Natl Acad Sci U S A. 1985 Jan;82(2):488-92 PMID: 3881765
  21. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.
    Cell. 1985 Jul;41(3):813-23 PMID: 2988790
  22. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus.
    Proc Natl Acad Sci U S A. 1985 Jul;82(13):4539-43 PMID: 2989831
  23. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).
    Science. 1985 Jul 5;229(4708):69-73 PMID: 2990040
  24. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.
    Science. 1985 Jul 5;229(4708):74-7 PMID: 2990041
  25. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.
    Science. 1986 May 9;232(4751):755-9 PMID: 3008338
  26. Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene.
    EMBO J. 1986 Jun;5(6):1367-71 PMID: 3015602
  27. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  28. Constitutive and inducible Saccharomyces cerevisiae promoters: evidence for two distinct molecular mechanisms.
    Mol Cell Biol. 1986 Nov;6(11):3847-53 PMID: 3540601
  29. Genome organization and transactivation of the human immunodeficiency virus type 2.
    Nature. 1987 Apr 16-22;326(6114):662-9 PMID: 3031510
  30. An inducible transcription factor activates expression of human immunodeficiency virus in T cells.
    Nature. 1987 Apr 16-22;326(6114):711-3 PMID: 3031512
  31. Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer.
    Proc Natl Acad Sci U S A. 1987 Jun;84(11):3658-62 PMID: 3035545
  32. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.
    J Virol. 1988 Jan;62(1):139-47 PMID: 3257102
  33. Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.
    Science. 1987 Dec 11;238(4833):1575-8 PMID: 2825351
  34. Definition of multiple, functionally distinct TATA elements, one of which is a target in the hsp70 promoter for E1A regulation.
    Cell. 1988 Mar 11;52(5):723-9 PMID: 2830991
  35. The SV40 enhancer contains two distinct levels of organization.
    Nature. 1988 May 5;333(6168):40-5 PMID: 2834649
  36. Characterization of antigen receptor response elements within the interleukin-2 enhancer.
    Mol Cell Biol. 1988 Apr;8(4):1715-24 PMID: 3260003
  37. HIV-1 tat trans-activation requires the loop sequence within tar.
    Nature. 1988 Jul 14;334(6178):165-7 PMID: 3386755
  38. trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: a quantitative analysis.
    J Virol. 1989 Dec;63(12):5501-4 PMID: 2479775
  39. Functional heterogeneity of mammalian TATA-box sequences revealed by interaction with a cell-specific enhancer.
    Nature. 1990 Mar 15;344(6263):260-2 PMID: 2156167
  40. Cooperative interactions between transcription factors Sp1 and OTF-1.
    Proc Natl Acad Sci U S A. 1990 Jun;87(12):4732-6 PMID: 2191301
  41. TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes.
    EMBO J. 1990 Dec;9(13):4417-23 PMID: 2124973
  42. Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes.
    J Virol. 1991 Mar;65(3):1414-9 PMID: 1995951
  43. Identification of a putative regulator of early T cell activation genes.
    Science. 1988 Jul 8;241(4862):202-5 PMID: 3260404
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1991-08-00
Pages
4350-8
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC248874
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]